Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study

on behalf of the TRANSFORM Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1953-1963
Number of pages11
JournalTransplantation
Volume103
Issue number9
DOIs
StatePublished - Sep 1 2019

ASJC Scopus Subject Areas

  • Transplantation

Cite this